| Literature DB >> 35529964 |
Mohamed Shaker S Adam1,2, Omar M El-Hady2, Farman Ullah3.
Abstract
ONO-Pincer Schiff base salicylidene (HSaln ligand) complexes with VO2+, UO2 2+, MoO2 2+ and Mn2+ ions (MSaln complexes = VOSaln, UO2Saln, MoO2Saln and MnSaln, respectively) were synthesized and fully characterized by different physico-chemical tools. The VOSaln complex was further treated with 1,10-phenanthroline which afforded a new VO-complex (VOSaln-Ph). All complexes and their ligands, as eco-friendly reagents, were explored for their biological potential as antibacterial and antifungal agents. Reactivity of MSaln complexes against the tested pathogen strains exhibited a remarkable inhibitory effect compared to the coordinated ligand (HSaln) and applicable standard drugs. Moreover, the MSaln complex-DNA interaction was investigated by ultraviolet-visible spectroscopy, viscosity and gel electrophoresis techniques affording binding strengths in the order: UO2Saln > MnSaln > MoO2Saln > VOSaln-Ph > VOSaln. Additionally, the biological potential of the investigated compounds was further explored by molecular docking to illustrate the nature of the drug-DNA interactions. All MSaln complexes show respectable anti-proliferative potential as anticancer agents against selected human carcinoma cell lines. Aside from the biological activities these complexes (MSaln complexes) were also investigated for catalytic efficiency in the Suzuki-Miyaura cross-coupling system of phenylboronic acid with 2-bromopyridine in water, sustainably. The results indicated that the MnSaln catalyst performed well with high yield. The catalytic potential of MnSaln was compared in water, water-ionic liquid mixtures and ionic liquids. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35529964 PMCID: PMC9074042 DOI: 10.1039/c9ra06816c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Distinctive elemental analysis, melting point, color, electronic and mass spectra (electrospray ionization mass spectra) HSaln ligand and its MSaln complexes at [compound] = 1 × 10−5 mol dm−3 in H2O at 25 °C
| Compound | MW (g mol−1) | Elemental analysis found%, (calc.%) | Color | Mp (°C) | Electronic transition spectra | Mass spectra ( | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| C | H | N |
|
| Assign. | [M + Na+] | [M − Na+] | ||||
| HSaln ligand | 343.29 | 49.25 (48.98) | 3.08 (2.94) | 3.81 (4.08) | Pale yellow | 164 | 325, 256 | 5894, 12 436 | n → π*, π → π* | ||
| VOSaln | 444.24 | 38.11 (37.85) | 2.98 (2.72) | 3.07 (3.15) | Dark green | 288 | 395, 310, 249 | 5073, 8211, 12 099 | LM-CT, n → π*, π → π* | 465, 467, 468, 469, 471 | 419, 420, 421, 422, 423 |
| VOSaln-Ph.·H2O | 606.43 | 51.76 (51.50) | 3.02 (2.99) | 7.36 (6.93) | Brownish green | >300 | 376, 322 | 4863, 8956 | LM-CT, n → π* | 610, 611, 612 | 565, 566 |
| UO2Saln | 629.31 | 27.10 (26.72) | 1.94 (1.60) | 2.12 (2.23) | Deep yellow | 304 | 388, 299, 271, 238 | 3418, 5874, 6693, 10 112 | LM-CT, n → π*, π → π*, π → π* | 604, 605, 606, 607 | 651, 652, 653 |
| MnSaln | 250.25 | 37.47 (37.35) | 3.44 (3.13) | 2.86 (3.11) | Brown | 294 | 416, 329, 284 | 3015, 7488, 18 894 | LM-CT, n → π*, π → π* | 471, 473, 474 | 425, 427, 428 |
| MoO2Saln | 287.24 | 34.66 (34.51) | 1.77 (2.07) | 2.53 (2.87) | Orange | >300 | 449, 320, 262 | 2322, 6152, 15 749 | LM-CT, n → π*, π → π* | 4645, 465 | 510, 511, 512 |
Specific infrared spectral assignments (, cm−1), distinguished magnetic moments (μ) and molar conductivity values (Λm) of HSaln ligand and its MSaln complexes ([compound] = 1 × 10−3 mol dm−3) in DMSO and DMF at ambient temperaturea
| Group | Compound | ||||||
|---|---|---|---|---|---|---|---|
| HSaln ligand | VOSaln | VOSaln-Ph | UO2Saln | MoO2Saln | MnSaln | ||
| O–H(water) | 3420(m br), 3342(m br) | 3368(m br) | 3403(w), 3135(w br) | 3352(w br), 3296(m br) | 3308(m br), 3233(m br) | ||
| O–H | 3401(w br) | ||||||
| C–Har | 3058(w) | 3062(w) | 3080(w) | 3074(w br) | 3124(w) | ||
| C | 1601(m) | 1597(s) | 1585(s) | 1589(m) | 1693(m) | 1643(m) | |
| C–O(phenolic) | 1494(w) | 1451(m) | 1455(m) | 1470 (m) | 1478(w) | 1455(m) | |
| C–O(carboxylic) | 1419(w) | 1422(m) | 1410(w) | 1409 (w) | 1403(m) | ||
| C | 1577(w) | 1518(s) | 1531(s) | 1559(m) | 1612(m) | 1589(m) | |
| C–N | 1236(m) | 1175(s) | 1154(m) | 1159(m) | 1162(s) | 1164(s) | |
| S–O− | 1382(w) | 1340(m) | 1372(m) | 1362(m) | 1378(w) | 1402(m) | |
| S | 1103(m) | 1142(m) | 1108(m) | 1099(m) | 1112(s) | 1107(s) | |
| M | 962(m) | 964(m) | 900(m) | 919(w) | |||
| M–O | 722(w) | 743(w) | 723(m) | 749(w) | 751(w) | ||
| M–N | 608(m) | 608(m) | 666(w) | 583(m) | 601(w) | ||
|
| DMSO | 139 | 140 | 130 | 117 | 125 | 142 |
| DMF | 158 | 154 | 149 | 142 | 151 | 163 | |
|
| — | 2.79 | 2.24 | — | — | 5.74 | |
br (broad), s (strong), m (moderate), w (weak), ar (aromatic CH), alph (aliphatic CH).
Scheme 1Diagrammatic scheme for the synthesis of MSaln complexes from HSaln ligand.
Fig. 1Electronic spectral scans of HSaln ligand and its MSaln complexes, [compound] = 1 × 10−5 mol dm−3 in an aqueous medium at room temperature.
Fig. 2Continuous variation plots for the stoichiometric molar ratios in MSaln complexes in an aqueous- medium at [MSaln] = 1 × 10−4 mol dm−3 and 25 °C.
Stability constants and thermodynamic parameters of MSaln complexes [complex] = 1 × 10−4 mol dm−3
| Complex |
|
| −Δf | −Δf | −Δf |
|---|---|---|---|---|---|
| VOSaln | 20 | 49.23 | 54.36 | 6.99 | 86.27 |
| 25 | 38.31 | 54.67 | |||
| 30 | 22.93 | 54.29 | |||
| 35 | 14.45 | 54.00 | |||
| 40 | 7.58 | 53.20 | |||
| VOSaln | 20 | 51.22 | 54.46 | 2.38 | 72.85 |
| 25 | 40.99 | 54.83 | |||
| 30 | 29.08 | 54.89 | |||
| 35 | 18.12 | 54.58 | |||
| 40 | 10.50 | 54.05 | |||
| MoO2Saln | 20 | 54.77 | 54.80 | 2.01 | 72.15 |
| 25 | 48.75 | 55.03 | |||
| 30 | 40.12 | 55.13 | |||
| 35 | 35.65 | 55.33 | |||
| 40 | 27.49 | 54.19 | |||
| MnSaln | 20 | 59.02 | 54.80 | 2.02 | 72.20 |
| 25 | 44.41 | 55.03 | |||
| 30 | 32.01 | 55.13 | |||
| 35 | 24.26 | 55.33 | |||
| 40 | 11.08 | 54.19 | |||
| UO2Saln | 20 | 62.18 | 54.93 | 11.50 | 32.52 |
| 25 | 55.82 | 55.60 | |||
| 30 | 47.62 | 56.13 | |||
| 35 | 39.65 | 56.59 | |||
| 40 | 30.31 | 56.81 |
Fig. 3Dissociation plot of MSaln complexes in an aqueous media at various pHs.
Antimicrobial bioassay of HSaln ligand and MSaln complexes versus various strains of bacteria
| Compound | Inhibition zone (mm) | |||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Conc. (μg mL−1) | 10 | 20 | 10 | 20 | 10 | 20 |
| HSaln ligand | 7 ± 0.23 | 10 ± 0.33 | 5 ± 0.21 | 8 ± 0.15 | 9 ± 0.18 | 14 ± 0.24 |
| VOSaln | 15 ± 0.17 | 34 ± 0.16 | 14 ± 0.43 | 33 ± 0.13 | 18 ± 0.14 | 40 ± 0.12 |
| VOSaln-Ph | 13 ± 0.21 | 30 ± 0.27 | 12 ± 0.24 | 29 ± 0.21 | 16 ± 0.11 | 36 ± 0.17 |
| MnSaln | 16 ± 0.18 | 36 ± 0.24 | 15 ± 0.14 | 34 ± 0.27 | 19 ± 0.16 | 42 ± 0.19 |
| MoO2Saln | 14 ± 0.11 | 33 ± 0.12 | 13 ± 0.04 | 32 ± 0.19 | 17 ± 0.05 | 38 ± 0.17 |
| UO2Saln | 17 ± 0.05 | 38 ± 0.27 | 16 ± 0.07 | 35 ± 0.19 | 20 ± 0.11 | 44 ± 0.25 |
| Gentamycin | 19 ± 0.71 | 40 ± 0.33 | 17 ± 0.15 | 37 ± 0.72 | 22 ± 0.93 | 46 ± 0.11 |
Antimicrobial bioassay of HSaln ligand and MSaln complexes versus various strains of fungi
| Compound | Inhibition zone (mm) | |||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Conc. (μg mL−1) | 10 | 20 | 10 | 20 | 10 | 20 |
| HSaln ligand | 4 ± 0.14 | 7 ± 0.16 | 3 ± 0.21 | 8 ± 0.34 | 5 ± 0.10 | 11 ± 0.07 |
| VOSaln | 22 ± 0.13 | 34 ± 0.37 | 13 ± 0.18 | 23 ± 0.18 | 14 ± 0.41 | 29 ± 0.17 |
| VOSaln-Ph | 18 ± 0.17 | 29 ± 0.12 | 9 ± 0.17 | 19 ± 0.12 | 10 ± 0.16 | 25 ± 0.15 |
| MnSaln | 21 ± 0.11 | 33 ± 0.27 | 12 ± 0.27 | 22 ± 0.22 | 13 ± 0.23 | 28 ± 0.13 |
| MoO2Saln | 19 ± 0.10 | 32 ± 0.12 | 11 ± 0.10 | 21 ± 0.09 | 12 ± 0.05 | 27 ± 0.12 |
| UO2Saln | 23 ± 0.14 | 36 ± 0.17 | 14 ± 0.11 | 24 ± 0.21 | 15 ± 0.13 | 30 ± 0.23 |
| Fluconazole | 24 ± 0.55 | 37 ± 0.62 | 14 ± 0.71 | 25 ± 0.90 | 16 ± 0.49 | 31 ± 0.88 |
MIC, minimum inhibitory zone, for antimicrobial assay of HSaln ligand and MSaln complexes
| Compound | Minimum inhibition concentration (MIC) μg mL−1 | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| HSaln ligand | 6.25 | 7.50 | 5.50 | 5.75 | 8.50 | 6.75 |
| VOSaln | 3.25 | 2.75 | 2.25 | 4.25 | 5.25 | 5.00 |
| VOSaln-Ph | 4.75 | 4.25 | 3.75 | 3.00 | 3.75 | 3.50 |
| MnSaln | 3.75 | 3.25 | 2.75 | 2.75 | 4.25 | 4.00 |
| MoO2Saln | 4.50 | 3.75 | 3.25 | 4.00 | 4.75 | 4.50 |
| UO2Saln | 2.75 | 2.50 | 1.75 | 2.25 | 3.50 | 3.00 |
Fig. 4Histogram showing MIC values for antimicrobial activity of HSaln ligand and MSaln complexes.
UV-visible spectroscopic parameters for the DNA–MSaln complexes interactiona
| Compound |
|
| Δ | Chromism |
| Δ | |
|---|---|---|---|---|---|---|---|
| % | Type | ||||||
| MnSaln | 251 | 240 | 11 | 4.00 | Hypo | 3.92 | −31.20 |
| 403 | 325 | 78 | 8.65 | ||||
| MoO2Saln | 252 | 252 | 0 | 3.80 | Hypo | 2.60 | −30.20 |
| 271 | 271 | 0 | 5.91 | ||||
| 289 | 288 | 1 | 9.23 | ||||
| 396 | 394 | 2 | 39.76 | ||||
| VOSaln-Ph | 251 | 252 | 1 | 2.14 | Hypo | 1.35 | −29.27 |
| 272 | 271 | 1 | 1.59 | ||||
| 289 | 288 | 1 | 3.03 | ||||
| UO2Saln | 252 | 252 | 0 | 1.65 | Hypo | 6.50 | −32.43 |
| 320 | 325 | 5 | 23.93 | ||||
| 386 | 386 | 0 | 44.62 | ||||
| VOSaln | 239 | 238 | 1 | 2.20 | Hypo | 1.70 | −29.18 |
| 252 | 251 | 1 | 2.10 | ||||
| 270 | 269 | 1 | 2.10 | ||||
| 288 | 286 | 2 | 2.58 | ||||
| 354 | 352 | 2 | 7.22 | ||||
| 382 | 376 | 6 | 19.05 | ||||
K b, mol−1 dm3.
Fig. 5The UV-vis spectral scans of UO2Saln in the buffer solution in absence and presence of DNA with interval time 15 min.
Fig. 6The UV-vis spectral scans of MnSaln complex in absence and presence of DNA with interval time 15 min.
Fig. 7The effect of MSaln complexes amounts on the CT-DNA relative viscosity at [DNA] = 0.5 mM and 25 °C.
Scheme 2Type of interaction of DNA–UO2Saln complex via intercalation and/or coordinated water replacement bindings.
Fig. 8The interaction of the studied reagents with CT-DNA was studied by agarose gel electrophoresis; where lane 1: DNA ladder; lane 2: CT-DNA + VOSaln-Ph; lane 3: CT- DNA + VOSaln; lane 4: CT-DNA + UO2Saln; lane 5: CT-DNA + MnSaln; lane 6: CT-DNA + MoO2Saln.
Fig. 9IC50 values of HSaln ligand and MSaln complexes against human colon carcinoma cells (HCT-116 cell line), hepatic cellular carcinoma cells (HepG-2) and breast carcinoma cells (MCF-7) cell line.
The molecular docking values for HSaln ligand and its MSaln complexes
| Compound |
|
|
|
|---|---|---|---|
| HSaln ligand | 1.09 | −2.2441 | −100.1223 |
| VOSaln | 2.67 | −4.1794 | −247.6790 |
| VOSaln-Ph | 2.05 | −4.0727 | −206.5358 |
| MnSaln | 4.33 | −4.4996 | −794.3703 |
| MoO2Saln | 3.91 | −4.3615 | −551.9431 |
| UO2Saln | 4.76 | −5.1609 | −975.1266 |
Fig. 10Molecular docking results of HSaln ligand and its MSaln complexes.
Scheme 3C–C cross-coupling system of phenylboronic acid and 2-bromopyridine catalyzed by MSaln complexes.
Suzuki–Miyaura cross coupling system of phenylboronic acid and 2-bromopyridine catalyzed by MSaln complexesa
| Catalyst | Yield (%) |
|---|---|
| No catalyst | 0 |
| VOSaln | 51 |
| VOSaln-Ph | 39 |
| MoO2Saln | 49 |
| MnSaln | 88 |
| UO2Saln | 50 |
Phenylboronic acid (1.0 mmol), 2-bromopyridine (1.1 mmol), base (K2CO3, 2.0 mmol) and catalyst (0.10 mmol) in 10 mL H2O, at 100 °C for 6 hours.
The yield percentages of the C–C product analyzed by GC-MS.
MnSaln complex catalyzed the Suzuki–Miyaura cross coupling system of phenylboronic acid and 2-bromopyridine in various ionic liquids
| Entry | Ionic liquid | Yield (%) |
|---|---|---|
| 1 | [bmim][Tf2N] | 90 |
| 2 | [bmim][Tf2N] : H2O (3 : 1) | 94 |
| 3 | [emim][Tf2N] | 87 |
| 4 | [emim][Tf2N] : H2O (3 : 1) | 91 |
| 5 | [omim][Tf2N] | 84 |
| 6 | [omim][Tf2N] : H2O (3 : 1) | 89 |
| 7 | [bmim][PF6] | 88 |
| 8 | [bmim][PF6] : H2O (3 : 1) | 90 |
Phenylboronic acid (1.0 mmol), 2-bromopyridine (1.1 mmol), base (K2CO3, 2.0 mmol) and catalyst (0.10 mmol) in 10 mL solvent or 6.7 mL solvent : 3.3 mL H2O (1 : 1), at 100 °C for 6 hours.
The yield percentages of the C–C product analyzed by GC-MS.
1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide.
1-Ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide.
1-Octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide.
1-Butyl-3-methylimidazolium hexafluorophosphate.
MnSaln complexes catalyzed the Suzuki–Miyaura C–C coupling reaction of phenylboronic acid and various aryl halides
| Entry | Aryl halide | Product | Yield (%) |
|---|---|---|---|
| 1 |
|
| 85 |
| 2 |
|
| 91 |
| 3 |
|
| 72 |
| 4 |
|
| 94 |
| 5 |
|
| 90 |
| 6 |
|
| 89 |
| 7 |
|
| 87 |
| 8 |
|
| 74 |
Phenylboronic acid (1.0 mmol), aryl halide (1.1 mmol), base (K2CO3, 2.0 mmol) and catalyst (0.10 mmol) in 10 mL H2O, at 100 °C for 6 hours.
The yield percentages of the C–C product analyzed by GC-MS.